CLASS II-IA EXPRESSION BY ACTIVATING T CELLS
CLASS II-IA EXPRESSION BY ACTIVATING T CELLS
批准号:
3135737
负责人:
KAREN S ZIER
金额:
$15.69万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-07-01 至 1990-11-30
中文摘要
HLA复合体内编码的抗原起着重要的作用
英文摘要
Antigens coded for within the HLA complex play an important
role in the control of immune responses. Presently, three major
classes of HLA antigens can be defined: 1) Class I products,
coded for by the HLA-A,B, and C loci, 2) Class II (Ia) products,
coded for by the HLA-DR,DQ and DP loci and 3) Class III products
which code for components involved in the complement cascade.
Class I antigens are expressed by all mononuclear blood cells.
Class II antigens, however, have a limited tissue distribution.
They are expressed by B cells, monocytes, and by activated but
not by resting T cells.
It has long been appreciated that Class II (Ia) molecules expressed
on monocytes and B cells are responsible for the regulation of the
immune system. Specifically, they play a critical role 1) in
antigen presentation, 2) in the communication between T cells and
B cells and between T cells and macrophages, and 3) in influencing
susceptibility to certain diseases. While Class II expression by
activated T cells has not been well studied, recent evidence
suggests that they may be involved in T cell function. For
example, it was reported that the addition of anti-Class II
monoclonal antibodies inhibited the proliferation of activated T
cells. This suggested that Class II antigens on T cells might
influence the transmission of signals which trigger cell
proliferation and the development of functional ability. The
principal aim of this proposal is to define the relationship between
Class II gene expression and T cell activation and function.
We will achieve our goal 1) by studying the transcription of the
three types of Class II genes (DR, DQ, DP) in relation to two
other genes turned on during T cell activation, the IL-2 molecule
and its receptor (Tac), and in relation to the initiation of
proliferation, 2) and by examining whether there are qualitative
or quantitative differences in the accumulation of Class II mRNA
by T cell clones with different functional activities. Elucidating
the mechanism and significance of Class II gene expression in
activated T cells will have major implications on the design of
new approaches for immunomodulation in basic research, as well
as in clinical settings.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Negative signal transmission through class II molecules on activated T cells.
通过激活的 T 细胞上的 II 类分子传递负信号。
DOI:
10.1016/0198-8859(91)90023-3
发表时间:
1991
期刊:
Human immunology
影响因子:
2.7
作者:
[Urban,ND, Zier,KS]
通讯作者:
Zier,KS
HLA class II mRNA accumulation by activated human T cells following growth in conditioned medium.
在条件培养基中生长后,激活的人 T 细胞积累 HLA II 类 mRNA。
DOI:
--
发表时间:
1989
期刊:
Clinical and experimental immunology
影响因子:
4.6
作者:
[Gansbacher,B, Zier,KS]
通讯作者:
Zier,KS
The control of class II expression on T cells is independent of the regulation of Tac and the induction of proliferation.
T 细胞上 II 类表达的控制独立于 Tac 的调节和增殖的诱导。
DOI:
10.1111/j.1365-2249.1991.tb02967.x
发表时间:
1991
期刊:
Clinical and experimental immunology
影响因子:
4.6
作者:
[Salvadori,S, Pizzimenti,A, Cohen,S, Zier,KS]
通讯作者:
Zier,KS
The response pattern of human T cells to stimulation following expansion in IL-2.
人类 T 细胞在 IL-2 扩增后对刺激的反应模式。
DOI:
10.3109/08820139109026243
发表时间:
1991
期刊:
Immunological investigations
影响因子:
2.8
作者:
[Shah,U, Cutilli,JR, Zier,KS]
通讯作者:
Zier,KS
Post-transcriptional regulation of MHC class II expression in human T cells.
人类 T 细胞中 MHC II 类表达的转录后调控。
DOI:
10.1016/0008-8749(92)90103-v
发表时间:
1992
期刊:
Cellular immunology
影响因子:
4.3
作者:
[Caplen,HS, Salvadori,S, Gansbacher,B, Zier,KS]
通讯作者:
Zier,KS
共 6 条
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2104722
-
项目类别:
-
资助金额:$19.38万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2443072
-
项目类别:
-
资助金额:$20.84万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
ABNORMAL TCR/CD3 SIGNAL TRANSDUCTION IN CANCER
-
批准号:2104723
-
项目类别:
-
资助金额:$20.04万
-
财政年份:1995
-
负责人:KAREN S ZIER
-
依托单位:
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
-
批准号:3145570
-
项目类别:
-
资助金额:$16.61万
-
财政年份:1990
-
负责人:KAREN S ZIER
-
依托单位:
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
-
批准号:3145571
-
项目类别:
-
资助金额:$17.27万
-
财政年份:1990
-
负责人:KAREN S ZIER
-
依托单位:
DECREASED IL-2 SYNTHESIS IN TYPE I DIABETES
-
批准号:3145569
-
项目类别:
-
资助金额:$16.0万
-
财政年份:1990
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
-
批准号:3135738
-
项目类别:
-
资助金额:$8.17万
-
财政年份:1988
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
-
批准号:3135733
-
项目类别:
-
资助金额:$15.24万
-
财政年份:1986
-
负责人:KAREN S ZIER
-
依托单位:
CLASS II (IA) EXPRESSION BY ACTIVATED T CELLS
-
批准号:3135736
-
项目类别:
-
资助金额:$5.87万
-
财政年份:1986
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132297
-
项目类别:
-
资助金额:$12.95万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132299
-
项目类别:
-
资助金额:$13.5万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
DETECTION OF HUMAN MINOR ALLOANTIGENS USING CTL LINES
-
批准号:3132300
-
项目类别:
-
资助金额:$14.2万
-
财政年份:1984
-
负责人:KAREN S ZIER
-
依托单位:
PILOT--ABNORMAL IMMUNE MECHANISMS IN INSULIN DEPENDENT DIABETICS
-
批准号:4689197
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:KAREN S ZIER
-
依托单位:
INDUCTION OF CLASS II GENE EXPRESSION IN ACTIVATED T CELLS
-
批准号:3954145
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:KAREN S ZIER
-
依托单位: